Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cancer patients receiving platinum-based chemotherapy adequate bone marrow, hepatic and renal function~Exclusion Criteria:~* Pregnancy~* Serious concomitant diseases, in the invesgator´s criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intravenous palonosetron (Type: ACTIVE_COMPARATOR): Intravenous palonosetron: control arm (standard treatment)
- subcutaneous palonosetron (Type: EXPERIMENTAL): subcutaneous palonosetron

Based on this trial design, predict the completion outcome and termination type (if applicable).